SCHEMBL3860415

SCHEMBL3860415

CC[C@H](C)Nc1cc(C(=O)OC)cc(C2OCCCO2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
HCAR3 P49019 3/20 0.36
HSD17B10 Q99714 1/20 0.36
BACE1 P56817 1/20 0.34
LMNA P02545 1/20 0.34
KDM5A P29375 1/20 0.34
HTT P42858 2/20 0.33
STAT3 P40763 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
GAA P10253 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
BCHE P06276 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3860420 1.00 ALDH1A1 (0.37) ALDH1A1HCAR3HSD17B10BACE1LMNA
SCHEMBL3854265 0.90 HCAR3 (0.43) ALDH1A1HCAR3HSD17B10BACE1HTT
SCHEMBL3854267 0.90 HCAR3 (0.43) ALDH1A1HCAR3HSD17B10BACE1HTT
SCHEMBL5173042 0.85 HCAR3 (0.31) HCAR3BACE1
SCHEMBL3853799 0.76 ALDH1A1 (0.46) ALDH1A1HSD17B10LMNAKDM4ENPC1
SCHEMBL3853513 0.76 HCAR3 (0.43) ALDH1A1HCAR3HSD17B10LMNASTAT3
SCHEMBL3853514 0.76 HCAR3 (0.43) ALDH1A1HCAR3HSD17B10LMNASTAT3
SCHEMBL3855146 0.74 BACE1 (0.47) ALDH1A1HCAR3HSD17B10BACE1LMNA
SCHEMBL3855149 0.74 BACE1 (0.47) ALDH1A1HCAR3HSD17B10BACE1LMNA
SCHEMBL3855317 0.73 HCAR3 (0.42) ALDH1A1HCAR3HSD17B10LMNASTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618978-B2 Amides as BACE inhibitors ELI LILLY AND COMPANY (US) 2009-11-17 US disclosed
US-7585885-B2 Pyrrolidine derivatives useful as BACE inhibitors ELI LILLY AND COMPANY (US) 2009-09-08 US disclosed
US-20070225372-A1 Amides as Bace Inhibitors ELI LILLY AND COMPANY 2007-09-27 US disclosed
US-20070213331-A1 PYRROLIDINE DERIVATIVES USEFUL AS BASE INHIBITORS ELI LILLY AND COMPANY 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225372-A1 Amides as Bace Inhibitors BACE2, BACE1, APP ALDH1A1 661/4885HCAR3 1734/4885HSD17B10 942/4885
US-20070213331-A1 PYRROLIDINE DERIVATIVES USEFUL AS BASE INHIBITORS BACE1, BACE2, PSEN1 ALDH1A1 1523/4885HCAR3 3196/4885HSD17B10 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.